Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model

OBJECTIVES: Dopamine-replacement utilizing L-DOPA is still the mainstay treatment for Parkinson’s disease (PD), but often leads to development of L-DOPA-induced dyskinesia (LID), which can be as debilitating as the motor deficits. There is currently no satisfactory pharmacological adjunct therapy. T...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Res Notes
Auteurs principaux: Bartlett, Mitchell J., So, Lisa Y., Szabò, Lajos, Skinner, David P., Parent, Kate L., Heien, Michael L., Vanderah, Todd W., Polt, Robin, Sherman, Scott J., Falk, Torsten
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2020
Sujets:
Research Note
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066739/
https://ncbi.nlm.nih.gov/pubmed/32164786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-020-04994-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires